Chapter 152
Metabolic Disorders and the Skin
Fatma Al Jasmi,
Hassan Galadari,
Peter T. Clayton,
Emma J. Footitt,
Fatma Al Jasmi
College of Medicine and Health Science, United Arab Emirates University, Al Ain, United Arab Emirates
Search for more papers by this authorHassan Galadari
College of Medicine and Health Science, United Arab Emirates University, Al Ain, United Arab Emirates
Search for more papers by this authorPeter T. Clayton
Institute of Child Health, University College London with Great Ormond Street Hospital for Children NHS Trust, London, UK
Search for more papers by this authorEmma J. Footitt
Institute of Child Health, University College London with Great Ormond Street Hospital for Children NHS Trust, London, UK
Search for more papers by this authorFatma Al Jasmi,
Hassan Galadari,
Peter T. Clayton,
Emma J. Footitt,
Fatma Al Jasmi
College of Medicine and Health Science, United Arab Emirates University, Al Ain, United Arab Emirates
Search for more papers by this authorHassan Galadari
College of Medicine and Health Science, United Arab Emirates University, Al Ain, United Arab Emirates
Search for more papers by this authorPeter T. Clayton
Institute of Child Health, University College London with Great Ormond Street Hospital for Children NHS Trust, London, UK
Search for more papers by this authorEmma J. Footitt
Institute of Child Health, University College London with Great Ormond Street Hospital for Children NHS Trust, London, UK
Search for more papers by this authorBook Editor(s):Peter Hoeger,
Veronica Kinsler,
Albert Yan,
John Harper,
Arnold Oranje,
Christine Bodemer,
Margarita Larralde,
David Luk, Vibhu Mendiratta,
Diana Purvis,
Peter Hoeger
Search for more papers by this authorVeronica Kinsler
Search for more papers by this authorAlbert Yan
Search for more papers by this authorJohn Harper
Search for more papers by this authorArnold Oranje
Search for more papers by this authorChristine Bodemer
Search for more papers by this authorMargarita Larralde
Search for more papers by this authorVibhu Mendiratta
Search for more papers by this authorDiana Purvis
Search for more papers by this authorSummary
Metabolic disorders, both inherited and acquired, result from enzyme deficiency or overload, leading to accumulation or deficiency of a specific metabolite. These are generally multisystem disorders and frequently present with cutaneous features. Knowledge and recognition of these cutaneous features by the paediatric dermatologist can lead to early diagnosis and initiation of therapy, and there is evidence that early management may improve outcome in some diseases. This chapter discusses the cutaneous manifestations and management of metabolic diseases.
References
-
Saudubray JM, Charpentier C. Clinical approach to inherited metabolic diseases. In: CR Scriver, AL Beaudet, WS Sly et al. (eds) The Metabolic and Molecular Bases of Inherited Disease. Clinical Phenotypes: Diagnosis/Algorithms, 8th edn. New York: McGraw-Hill, 2000: 1327–407.
10.1007/978-3-662-04285-4_1 Google Scholar
-
Saudubray JM, Ogier de Baulny H, Charpentier C. Clinical approach to inherited metabolic diseases. In: J Fernandes, JM Saudubray, G Berghe (eds) Inborn Metabolic Diseases: Diagnosis and Treatment, 3rd revised edn. Berlin: Springer Verlag, 2000, pp. 3–41.
10.1007/978-3-662-04285-4_1 Google Scholar
- Saudubray JM, Ogier H, Bonnefont JP et al. Clinical approach to inherited metabolic disease in the neonatal period: a 20-year survey. J Inher Metab Dis 1989; 12(Suppl 1): 25–41.
References
- Güttler F. Hyperphenylalaninaemia. Diagnosis and classification of the various types of phenylalanine hydroxylase deficiency in childhood. Acta Pediatr Scand 1980; 280(Suppl): 1–80.
- Fölling A. Uber Ausscheidung von Phenylbrenztraubensaüre in den Harn als Stoffwechselanomalie in Verbindung mit Imbezillität. Höppe-Seylers Z Physiol Chem 1934; 227: 169.
- Bickel H, Gerrad I, Hickmans EM. Influence of phenylalanine intake on phenylketonuria. Lancet 1953; ii: 812.
- Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 1963; 32: 338–43.
- Scriver CR, Kaufman S. Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. In: CR Scriver, AL Beaudet, WS Sly (eds) The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 2001: 1667–724.
- Fitzpatrick TB, Miyamoto M. Competitive inhibition of mammalian tyrosinase by phenylalanine and its relationship to hair pigmentation in phenylketonuria. Nature 1957; 179(4552): 199–200.
- Ozalp I, Coskun T, Ceyhan M et al. Incidence of phenylketonuria and hyperphenylalaninemia in a sample of the newborn population. J Inherit Metab Dis 1986; 9(Suppl 2): 237.
- Urrets-Zavalía JA, Espósito E, Garay I et al. The eye and the skin in nonendocrine metabolic disorders. Clin Dermatol 2016; 34: 166–82.
- Smith I, Cook B, Beasley M. Review of neonatal screening programme for phenylketonuria. BMJ 1991; 303: 333–5.
- Paige DG, Clayton P, Bowron A et al. Richner–Hanhart syndrome (oculocutaneous tyrosinaemia type II). J Roy Soc Med 1992; 85: 759–60.
- Goldsmith LA, Kang ES, Bienfang DC et al. Tyrosinemia with plantar and palmer keratosis and keratitis. J Pediatr 1973; 83: 798–805.
- Hargrove JL, Scoble HA, Mathews WR et al. The structure of tyrosine aminotransferase. J Biol Chem 1898; 264: 45e53.
- Rabinowitz LG, Williams LR, Anderson CE et al. Painful keratoderma and photophobia: hallmarks of tyrosinemia type II. J Pediatr 1995; 126: 266–9.
- Charfeddine C, Monastiri K, Mokni M et al. Clinical and mutational investigations of tyrosinemia type II in Northern Tunisia: identification and structural characterization of two novel TAT mutations. Mol Genet Metab 2006; 88: 184–91.
- Barr DGD, Kirk JM, Laing SC. Outcome of tyrosinaemia type II. Arch Dis Child 1991; 66: 1249–50.
- Zatkova A. An update on molecular genetics of Alkaptonuria (AKU). J Inherit Metab Dis 2011; 34: 1127–36.
- Garrod AE. The Croonian Lectures on inborn errors of metabolisms. Lecture II. Alkaptonuria. Lancet 1908; ii: 73.
- La Du BN, Zannoni VG, Laster L, Seegmiller JE. The nature of the defect in tyrosine metabolism in alkaptonuria. J Biol Chem 1958; 230: 251–60.
- Fernández-Cañón JM, Granadino B, Beltrán-Valero de Bernabé D, et al. The molecular basis of alkaptonuria. Nat Genet 1996; 14: 19–24.
- Ramesh V, Avninder S. Endogenous ochronosis with a predominant acrokeratoelastoidosis-like presentation. Int J Dermatol 2008; 47: 873–5.
-
La Du BN. Alkaptonuria. In: CR Scriver, AL Beaudet, WS Sly, D Valle, B Vogelstein (eds) The Metabolic and Molecular Bases of Inherited Disease, 8 edn. New York: McGraw-Hill, 2001: 2109–23.
10.1006/rwgn.2001.0025 Google Scholar
- Ludwig GD, Toole JF, Wood JC. Ochronosis from quinacrine (atabrine). Ann Intern Med 1963; 59: 378–84.
- Suwannarat P, Phornphutkul C, Bernardini I et al. Minocycline-induced hyperpigmentation masquerading as alkaptonuria in individuals with joint pain. Arthritis Rheum 2004; 50: 3698–701.
- de Haas V, Carbasius Weber EC, de Klerk JB et al. The success of dietary protein restriction in alkaptonuria patients is age-dependent. J Inherit Metab Dis 1998; 21: 791–8.
- Anikster Y, Nyhan WL, Gahl WA. NTBC and alkaptonuria. Am J Hum Genet 1998; 63: 920.
- Mudd SH, Skovby F, Levy HL et al. The natural history of homocystinuria due to cystathionine β-synthase deficiency. Am J Hum Genet 1985; 94: 1–31.
- Mudd SH, Finkelstein JD, Irreverre F, Laster L. Homocystinuria: an enzymatic defect. Science 1964; 143: 1443–5.
- Gerritsen T, Vaughn JG, Waisman HA. The identification of homo- cystine in the urine. Biochem Biophys Res Commun 1962; 9: 493–6.
- Mudd SH, Levy HL, Krans JP. Disorders of trans-sulfuration. In: CR Scriver, AL Beaudet, WS Sly et al. (eds) The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 2001: 2007–56.
- Chen X, Wang L, Fazlieva R, Kruger WD. Contrasting behaviors of mutant cystathionine beta-synthase enzymes associated with pyridoxine response. Hum Mutat 2006; 27: 474–82.
- Rish O, Townsend D, Berry SA et al. Tyrosine inhibition due to interaction of homocysteine with copper: the mechanism for reversible hypopigmentation in homocystinuria due to cystathionine β-synthase deficiency. Am J Hum Genet 1995; 57: 127–32.
- Wilcken DEN, Wilcken B, Dudman NPD et al. Homocystinuria – the effect of betaine in the treatment of patients not responsive to pyridoxine. N Engl J Med 1983; 309: 448–53.
References
- Fenton WA, Gravel RA, Rosenblatt DSLE. Disorders of propionate and methylmalonate metabolism. In: CR Scriver, AL Beaudet, WS Sly et al. (eds) The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 2001: 2165–94.
- De Raeve I, de Meirleir L, Ramet J et al. Acrodermatitis enteropathica-like cutaneous lesions in organic acidurias. J Pediatr 1994; 124: 416–20.
- Touati G, Valayannopoulos V, Mention K et al. Methylmalonic and propionic acidurias: management without or with a few supplements of specific amino acid mixtures. J Inher Metab Dis 2006; 29: 288–99.
- Leonard JV, Walter JH, McKiernan PJ. The management of organic acidaemias: the role of transplantation. J Inher Metab Dis 2001; 24: 309–11.
- Koopman RJJ, Happle R. Cutaneous manifestations of methylmalonic acidemia. Arch Dermatol Res 1990; 282: 272–3.
- Bodemer C, de Prost Y, Bachollot B et al. Cutaneous manifestations of methylmalonic and propionic acidemia: a description of 38 cases. Br J Dermatol 1994; 131: 93–9
- Burlina AB. Hepatocyte transplantation for inborn errors of metabolism. J Inher Metab Dis 2004; 27: 373–83.
- Saudubray JM, Ogier H, Bonnefont JP et al. Clinical approach to inherited diseases in the neonatal period: a 20-year-survey. J Inher Met Dis 1989; 12(Suppl 1): 1 –17.
- Wolf B, Heard GS, Weisbecker KA et al. Biotinidase deficiency: initial clinical features and rapid diagnosis. Ann Neurol 1985; 18: 614–17.
- Jay AM, Conway RL, Feldman GL et al. Outcomes of individuals with profound and partial biotinidase deficiency ascertained by newborn screening in Michigan over 25 years. Genet Med 2015; 17: 205–9.
Reference
- Scriver ER, Mahon B, Levy HL et al. The Hartnup phenotype: mendelian transport disorder, multifactorial disease. Am J Hum Genet 1987; 40: 401.
References
- Gaucher PCE. De l'epithelioma primitif de la rate, hypertrophie idiopathique de la rate sans leucemie [academic thesis]. Paris, 1882.
- Brady RO, Kanfer JN, Shapiro D. Metabolism of glucosylceramidase. II. Evidence of an enzymatic deficiency in Gaucher's disease. Biochem Biophys Res Commun 1965; 18: 221–5.
- Liu K, Commens C, Chong R, Jaworski R. Collodion babies with Gauchers disease. Arch Dis Child 1988; 63: 854–6.
- Beutler E, Grabowski GA. Gaucher disease. In: CR Scriver, AL Beaudet, WS Sly, D Valle (eds) Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 2001: 3635.
- Stone DL, Carey WF, Christodoulou J et al. Type 2 Gaucher disease: the collodion baby phenotype revisited. Arch Dis Child Fetal Neonatal Ed 2000; 82: F163–6.
- Weiss K, Gonzalez A, Lopez G et al. the clinical management of type 2 Gaucher disease. Mol Genetics Metab 2015; 114: 110–22.
-
Van Diggelen OP, Schindler D, Kleijer WJ et al. Lysosomal α-N-acetylgalactosaminidase deficiency: a new inherited metabolic disease. Lancet 1987; ii: 804.
10.1016/S0140-6736(87)92542-6 Google Scholar
- Kanzaki T, Wang AM, Desnick RJ. Lysosomal α-N-acetylgalactosaminidase deficiency, the enzymatic defect in angiokeratoma corporis diffusum with glycopeptiduria. J Clin Invest 1991; 88: 707.
-
Anderson W. A case of angiokeratoma. Br J Dermatol 1898; 10: 113.
10.1111/j.1365-2133.1898.tb16317.x Google Scholar
-
Fabry J. Ein Beitrag zur Kenntnis der Purpura haemorrhagica nodularis. Arch Dermatol Syph 1898; 43: 187.
10.1007/BF01986897 Google Scholar
- Kint JA. Fabry's disease, α-galactosidase deficiency. Science 1970; 167: 1268.
- Albano LM, Rivitti C, Bertola DR et al. Angiokeratoma: a cutaneous marker of Fabry's disease. Clin Exp Dermatol 2010; 35: 505–8.
- Zampetti A, Orteu CH, Antuzzi D et al. Angiokeratoma: decision- making aid for the diagnosis of Fabry disease. Br J Dermatol. 2012; 166: 712–720.
- Hogarth V, Dhoat S, Mehta AB et al. Late-onset Fabry disease associated with angiokeratoma of Fordyce and multiple cherry angiomas. Clin Exp Dermatol 2011; 36: 506–8.
- Ries M, Ramaswami U, Parini R et al. The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents. Eur J Pediatr 2003; 162: 767–72.
- Lidove O, Ramaswami U, Jaussaud R et al. Hyperhidrosis: a new and often early symptom in Fabry disease. International experience and data from the Fabry Outcome Survey. Int J Clin Pract 2006; 60: 1053–9.
- Newton JA, McGibbon HD. The treatment of multiple angiokeratoma with the argon laser. Clin Exp Dermatol 1987; 12: 23.
- Durand P, Borrone C, Della Cella G. Fucosidosis. J Pediatr 1969; 75: 665–74.
- Epinette W, Norins A, Drew A, Zeman W. Angiokeratoma Corporis Diffusum with a-L-fucosidase deficiency. Arch Dermatol 1973; 107: 754.
- Kanzaki T. [Lysosomal storage diseases with angiokeratoma corporis diffusum]. Nippon Rinsho 1995; 53: 3062.
- Willems PJ, Gatt R, Darby JK et al. Fucosidosis revisited: a review of 77 patients. Am J Med Genet 1991; 38: 111.
- Porfiri B, Ricci R, Seminara D, Segni G. Ultrastructural studies of type II fucosidosis. Arch Dermatol Res 1981; 270: 57.
- Fleming C, Rennie A, Fallowfield M, McHenry PM. Cutaneous manifestations of fucosidosis. Br J Dermatol 1997; 136: 594.
- Kanitakis J, Allombert C, Doebelin B et al. Fucosidosis with angiokeratoma. Immunohistochemical and electronmicroscopic study of a new case and literature review. J Cutan Pathol 2005; 32: 506–11.
- Miranda CO, Brites P, Mendes Sousa M, Teixeira CA. Advances and pitfalls of cell therapy in metabolic leukodystrophies. Cell Transplant 2013; 22: 189–204.
- Butterworth J, Guy GJ. α-l-fucosidase of human skin fibroblasts and amniotic fluid cells in tissue culture. Clin Genet 1977; 12: 297.
- Neufeld EF, Muenzer J. The mucopolysaccharidoses. In: CR Scriver, AL Beaudet, WS Sly et al. (eds) The Metabolic and Molecular Bases of Inherited Disease, 7th edn. New York: McGraw-Hill, 1995: 2465–94.
- Prystowsky SD, Maumenee IH, Freeman RG et al. A cutaneous marker in the Hunter syndrome a report of four cases. Arch Dermatol 1977; 113: 602–5.
- Sapadin AN, Friedman IS. Extensive Mongolian spots associated with Hunter syndrome. J Am Acad Dermatol 1998; 39: 1013–5.
-
O'Brien JS, Stern MB, Landing BH et al. Generalized gangliosidosis. Am J Dis Child 1965; 109: 388.
10.1001/archpedi.1965.02090020340014 Google Scholar
- Weissbluth M, Esterly NB, Caro WA. Report of an infant with GM1 gangliosidosis type I and extensive and unusual mongolian spots. Br J Dermatol 1981; 104: 195–200.
- Beratis NG, Varvarigou-Frimas A, Beratis S, Sklower SL. Angiokeratoma corporis diffusum in GM1 gangliosidosis, Type 1. Clinical Genetics 1989; 36: 59–64.
- Moser HW, Moser AB, Chen WW. Ceramidase deficiency: Farber lipogranulomatosis. In: CR Scriver, AL Beaudet, WS Sly et al. (eds) The Metabolic and Molecular Bases of Inherited Disease, 7th edn. New York: McGraw-Hill, 1995: 1645–53.
-
Fensom AH, Benson PI, Neville BRG et al. Prenatal diagnosis of Farber's disease. Lancet 1979; ii: 990.
10.1016/S0140-6736(79)92562-5 Google Scholar
- Mancini GMS, Stojanov L, Willemsen R et al. Juvenile hyaline fibromatosis. Dermatology 1999; 198: 18–25.
- Schuchman EH. Acid ceramidase and the treatment of ceramide diseases: the expanding role of enzyme replacement therapy. Biochim Biophys Acta 2016; 1862: 1459–71.
References
- Verhoeven NM, Huck JH, Roos B et al. Transaldolase deficiency: liver cirrho- sis associated with a new inborn error in the pentose phosphate pathway. Am J Hum Genet 2001; 68: 1086–92.
- Heinrich PC, Morris HP, Weber G. Behavior of transaldolase (EC 2.2.1.2) and transketolase (EC 2.2.1.1) activities in normal, neoplastic, differentiating, and regenerating liver. Cancer Res 1976; 36: 3189–97.
- Hanczko R, Fernandez DR, Doherty E et al. Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase- deficient mice by N-acetylcysteine. J Clin Invest 2009; 119: 1546–57.
- Tylki-Szymanska A, Stradomska TJ, Wamelink MM et al. Transaldolase deficiency in two new patients with a relative mild phenotype. Mol Genet Metab 2009; 97: 15–17.
- Al-Shamsi AM, Ben-Salem S, Hertecant J, Al-Jasmi F. Transaldolase deficiency caused by the homozygous p.R192C mutation of the TALDO1 gene in four Emirati patients with considerable phenotypic variability. Eur J Pediatr 2015; 174: 661–8.
- Ferreira C, Wang H. Prolidase deficiency. June 25 2015. In: RA Pagon, MP Adam, HH Ardinger et al. (eds) GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2016. Available from http://www.ncbi.nlm.nih.gov/books/NBK299584/
- Powell GF, Rasco MA, Maniscalco RM. A prolidase deficiency in man with iminopeptiduria. Metabolism 1974; 23: 505–13.
References
- Brown MS, Goldstein JC. A receptor mediated pathway of cholesterol homeostasis. Science 1986; 232: 34–47.
- Fredricksen DS, Lees RS. A system for phenotyping hyperlipoproteinaemia. Circulation 1965; 31: 321–7.
- Santamarina-Fojo S. Genetic dyslipoproteinemias: role of lipoprotein lipase and apolipoprotein C-II. Curr Opin Lipidol 1992; 3: 186–95.
- McKee P. Pathology of the Skin, 2nd edn. London: Mosby Wolfe, 1996: 1–7, 10.
- Crowe MJ, Gross DJ. Eruptive xanthoma. Cutis 1992; 50: 31–2.
- Winkelmann RK. Cutaneous syndromes of non-X histiocytosis. A review of the macrophage–histiocyte diseases of the skin. Arch Dermatol 1981; 117: 667–72.
- Soong VY, Rabkin MS, Thomas JM. Nodular lesions on the face and trunk: xanthoma disseminatum. Arch Dermatol 1991; 1127: 1717–22.
- Wiegman A, Gidding SS, Watts GF et al. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment. Eur Heart J 2015; 36: 2425–37.
- Venero CV, Thompson PD. Managing statin myopathy. Endocrinol Metab Clin North Am 2009; 38: 121–36.
References
- Brandt T. Dermatitis in children with disturbances of general condition and absence of food. Acta Derm Venereol 1936; 17: 513–46.
- Atherton DJ, Muller DPR, Aggett PJ et al. A defect in zinc uptake by jejunal biopsies in acrodermatitis enteropathica. Clin Sci 1970; 56: 505–7.
- Neldner KH, Hambridge KM, Walravens PA. Acrodermatitis enteropathica. Int J Dermatol 1978; 17: 380–7.
- Koopman RJJ, Happle R. Cutaneous manifestations of methylmalonic acidemia. Arch Dermatol Res 1990; 282: 272–7.
- Bodemer C, de Prost Y, Bachollet B et al. Cutaneous manifestations of methylmalonic acidemia and propionic acidemia: a description of 38 cases. Br J Dermatol 1994; 131: 93–8.
References
- Furr HC. Carotenoids. In: R Macrae, RK Robinson, MJ Sadler (eds) Encyclopaedia of Food Science, Food Technology and Nutrition. London: Academic Press, 1993: 707–18.
- Malvy DJ, Burtschy B, Dostalova L et al. Serum retinol, β-carotene, β-tocopherol and cholesterol in healthy French children. Int J Epidemiol 1993; 22: 237–46.
- Greene CH, Blackford L. Carotenemia. M Clin N Am 1926; 10: 733–44.
- Almond S, Logan RFL. Carotinaemia. BMJ 1942; ii: 239–41.
- Cohen L. Observations on carotenaemia. Ann Intern Med 1958; 48: 219–27.
- Traber MG, Diamond SR, Lane JC et al. β-Carotene transport in human lipoproteins. Comparisons with β-tocopherol. Lipids 1994; 29: 665–9.
- Hu˚lková H, Svojanovský J, Sevela K et al. Systemic AL amyloidosis with unusual cutaneous presentation unmasked by carotenoderma. Amyloid 2014; 21: 57–6.
- Holland B, Welch AA, Unwin ID et al. McCance and Widdowson's The Composition of Foods, 5th edn. London: HMSO, 1991.
- Prince MR, Frisoli JK. Beta-carotene accumulation in serum and skin. Am J Clin Nutr 1993; 57: 175–81.
- Lloyd JK. Plasma lipid disorders. In: BE Clayton, JM Round (eds) Chemical Pathology and the Sick Child. Oxford: Blackwell Scientific Publications, 1984.
- Mordasini R, Klose G, Greten H. Secondary type II hyperlipoproteinemia in patients with anorexia nervosa. Metabolism 1978; 27: 71–9.
- Lindqvist A, Sharvill J, Sharvill DE, Anderson S. Loss-of-function mutation in carotenoid 15,15′-monooxygenase identified in a patient with hypercarotenaemia and hypovitaminosis Am J Nutr 2007; 137: 2346–50.
- Sharvill DE. Familial hypercarotinaemia and hypovitaminosis A. Proc Roy Soc Med 1970; 63: 605–6.
- McLaren DS, Zekian B. Failure of enzymic cleavage of β-carotene. The cause of vitamin A deficiency in a child. Am J Dis Child 1971; 121: 278–80.
- Monk BE. Metabolic carotenaemia. Br J Dermatol 1982; 106: 485–7.
- Svensson A, Vahlquist A. Metabolic carotenemia and carotenoderma in a child. Acta Derm Venereol 1995; 75: 70–1.
- Leung WC, Hessel S, Meplan C et al. Two common single nucleotide polymorphisms in the gene encoding beta-carotene 15,15’-monoxygenase alter beta-carotene metabolism in female volunteers. FASEB J 2009; 23: 1041–53.
- Lietz G, Oxley A, Leung W, Hesketh J. Single nucleotide polymorphisms upstream from the β-carotene 15,15'-monoxygenase gene influence provitamin A conversion efficiency in female volunteers. J Nutr 2012; 142: 161S–5S.
- Attard-Montalto S, Evans N, Sherwood RA. Carotenaemia with low vitamin A levels and low retinol-binding protein. J Inherit Metab Dis 1992; 15: 929–30.
- Seeliger MW, Biesalski HK, Wissinger B et al. Phenotype in retinol deficiency due to a hereditary defect in retinol binding protein synthesis. Invest Ophthal Vis Sci 1999; 40: 3–11.
- Chou CM, Nelson C, Tarle SA et al. Biochemical basis for dominant inheritance, variable penetrance, and maternal effects in RBP4 congenital eye disease. Cell 2015; 161: 634–46.
-
Shoenfeld Y, Shaklai M, Ben-Baruch N et al. Neutropenia induced by hypercarotenaemia. Lancet 1982; i: 1245.
10.1016/S0140-6736(82)92365-0 Google Scholar
- Kaspar P, Polsky A, Kudlova E et al. Carotenemia. Cesk-Pediatr 1991; 46: 275–7.
- Gangakhedkar A, Somerville R, Jelleyman T. Carotenemia and hepatomegaly in an atopic child on an exclusion diet for a food allergy. Australas J Dermatol 2017; 58: 42–4.
- Nishimura T. A correlation between carotenemia and biliary dyskinesia. J Dermatol 1993; 20: 287–92.
- Lobo GP, Amengual J, Palczewski G et al. Mammalian carotenoid-oxygenases: key players for carotenoid function and homeostasis. Biochim Biophys Acta 2012; 1821: 78–87.
- Someya K, Totsuka Y, Murakoshi M et al. The antioxidant effect of palm fruit carotene on skin lipid peroxidation in guinea pigs estimated by the chemiluminescence–HPLC method. J Nutr Sci Vitaminol Tokyo 1994; 40: 315–24.
- Rowe PM. Beta-carotene takes a collective beating. Lancet 1996; 347: 249.
- Pollitt N. Beta-carotene and the photodermatoses. Br J Dermatol 1975; 93: 721–4.
- Favaro RM, de-Souza NV, Batistal SM et al. Vitamin A status of young children in southern Brazil. Am J Clin Nutr 1986; 43: 852–8.
-
Honda T. Adverse effects of foods in genetic disorders. In: EFP Jelliffe, DB Jelliffe (eds) Adverse Effects of Foods. New York: Plenum Press, 1982: 389–96.
10.1007/978-1-4613-3359-3_33 Google Scholar
- Bilimoria S, Keczkes K, Williamson D et al. Hypercarotenaemia in weight watchers. Clin Exp Dermatol 1979; 4: 331–5.
